Legend Biotech Corporation

IPO

Legend Biotech Corporation is a biotech company in Somerset, United States, founded in 2014. It has raised $150.5M across 1 round, most recently a $150.5M Series A in April 2020.

In pursuit of cures.

Employees
1001–5000
Founded
2014
Business Model
B2B
Total Funding
$150.5M
Last Round
$150.5M Series AApr 2020
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.

About

Legend Biotech is a global, commercial-stage biotechnology company developing, manufacturing, and commercializing novel cell therapies. Founded in 2014 as an early-stage cell therapy company, it was among the first to engineer CAR-T cells targeting the BCMA protein and later partnered with Janssen Biotech to co-develop ciltacabtagene autoleucel. That therapy, CARVYKTI, was approved by the U.S. FDA in February 2022 and received conditional European approval in May 2022 for relapsed or refractory multiple myeloma. Today Legend advances a diversified next-generation pipeline across autologous, allogeneic, and in vivo platforms.

Summary

It lists 1001–5000 employees. It has raised $150.5M in total across 1 round, most recently a $150.5M Series A round in Apr 2020. Investors include Hudson Bay Capital Management, Lilly Asia Ventures and Vivo Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOInitial Public OfferingJun 2020
$487.3M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Legend Biotech Corporation on Indexed.vc
<a href="https://indexed.vc/companies/legend-biotech-corporation"><img src="https://indexed.vc/api/badge/company/legend-biotech-corporation" alt="Legend Biotech Corporation on Indexed.vc" width="260" height="76" /></a>